Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy

Sarcoma is one of the most severe forms of pediatric cancer and current therapies -chemotherapy and surgery- fail to eradicate the disease in half of patients. Preclinical studies combining new therapeutic approaches can be useful to design better therapies. On one hand, it is known that CXCR4 expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Vela, Maria, Bueno, David, González-Navarro, Pablo, Brito, Ariadna, Fernández, Lucía, Escudero, Adela, Valentín, Jaime, Mestre-Durán, Carmen, Arranz-Álvarez, Marina, Pérez de Diego, Rebeca, Mendiola, Marta, Pozo-Kreilinger, José Juan, Pérez-Martínez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688426/
https://www.ncbi.nlm.nih.gov/pubmed/31428099
http://dx.doi.org/10.3389/fimmu.2019.01814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688426/
https://www.ncbi.nlm.nih.gov/pubmed/31428099
http://dx.doi.org/10.3389/fimmu.2019.01814

Ejemplares similares